Correlation Between Entrada Therapeutics and 90331HPL1

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and US BANK NATIONAL, you can compare the effects of market volatilities on Entrada Therapeutics and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and 90331HPL1.

Diversification Opportunities for Entrada Therapeutics and 90331HPL1

0.07

Correlation Coefficient

Entrada Therapeutics  90331HPL1

Significant diversification

The 3 months correlation between Entrada and 90331HPL1 is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and 90331HPL1 go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and 90331HPL1

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 45.74 times less return on investment than 90331HPL1. But when comparing it to its historical volatility, Entrada Therapeutics is 19.23 times less risky than 90331HPL1. It trades about 0.04 of its potential returns per unit of risk. US BANK NATIONAL is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  9,516  in US BANK NATIONAL on September 24, 2024 and sell it today you would earn a total of  31.00  from holding US BANK NATIONAL or generate 0.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	62.85%
Values	Daily Returns

Entrada Therapeutics  vs.  US BANK NATIONAL

Entrada Therapeutics

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

US BANK NATIONAL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90331HPL1 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Entrada Therapeutics and 90331HPL1

The main advantage of trading using opposite Entrada Therapeutics and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.

The idea behind Entrada Therapeutics and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.